Blocking TNF-α in RA patients significantly reduces concentrations of interleukin (IL)-1, IL-6, IL-8, and granulocyte–macrophage colony-stimulating factor in synovial cell cultures compared to the placebo group [4]. The gene discussed is TNF; the disease is rheumatoid arthritis.